Teriflunomide added to interferon-β in relapsing multiple sclerosis

201278 citationsJournal Article

Authors

M. S. Freedman

Jerry S. Wolinsky

Abstract

This study provides Class II evidence that teriflunomide, 7 and 14 mg, added to IFNβ, is safe. The T1-Gd lesion burden was significantly reduced with both teriflunomide doses.

Topics & Keywords

Multiple Sclerosis Research Studies Fungal Plant Pathogen Control Systemic Lupus Erythematosus Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurology

Volume 78, Issue 23, pp. 1877-1885

DOI: 10.1212/wnl.0b013e318258f7d4

Field-Weighted Citation Impact: 10.86